menu search

Sutro biopharma reports full year 2022 financial results, business highlights and select anticipated milestones

– Sutro plans to initiate a Phase 2/3 registration-directed study of luvelta for patients with platinum resistant ovarian cancer in the second quart...

March 30, 2023, 8:30 pm

vaxcyte, inc. (pcvx) q4 2022 earnings call transcript

vaxcyte, Inc. (NASDAQ:PCVX ) Q4 2022 Earnings Conference Call February 27, 2023 4:30 PM ET Company Part...

February 27, 2023, 10:03 pm

vaxcyte to present at the svb securities global biopharma conference

SAN CARLOS, Calif., Feb. 07, 2023 (GLOBE NEWSWIRE) — vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage v...

February 7, 2023, 9:05 pm

vaxcyte has a bright future ahead

Not everything is negative in this bearish market. The healthcare sector is home to stocks with rosy prospects....

November 2, 2022, 3:01 pm

vaxcyte, inc. (pcvx) ceo grant pickering on q4 2021 results - earnings call transcript

vaxcyte, Inc. (PCVX) CEO Grant Pickering on Q4 2021 Results - Earnings Call Transcript...

February 28, 2022, 8:05 pm

vaxcyte, inc. (pcvx) ceo grant pickering on q4 2021 results - earnings call transcript

vaxcyte, Inc. (PCVX) CEO Grant Pickering on Q4 2021 Results - Earnings Call Transcript...

February 28, 2022, 8:05 pm

vaxcyte, inc. (pcvx) ceo grant pickering on q4 2021 results - earnings call transcript

vaxcyte, Inc. (PCVX) CEO Grant Pickering on Q4 2021 Results - Earnings Call Transcript...

February 28, 2022, 8:05 pm


Search within

Pages Search Results: